A2 Corporation has halved its losses in its 2008/09 financial year, the company’s preliminary results reveal.
The company, which owns and licenses technology to identify milk with the A2 beta casein protein it claims has health benefits, has announced a post-tax loss of $3.5 million or $2.7 million excluding abnormal costs for the 15 month period to June 30, 2009.
Last year the company reported a $6.3 million loss over the 12 months to March 31, 2008. Since then the A2 Corporation has changed to a mid-year reporting period.
In its report to NZX, A2 Corporation claimed financial improvements came from a two-pronged approach.
The first was the strengthening of its balance sheet with share placements to create a net cash position of $8.9 million, which was $7.1 million at the close of the financial year.
As a result the company expected to require no further capital unless an acquisition or purchase of assets was considered.
Secondly, improved operational performance was delivered from a restructure of the management team and a focus on procedures and accountability that saw previous losses reduced dramatically.
A deliberate strategy of making key markets profitable was also followed.
Its joint venture, Australian Dairy Products Australia (A2DPA) has traded profitably since December, except for April, due to a one-off cost, and finished the year with a $A500,000 ebit, compared with a loss of $A3.4 million last year.
The company signalled it expected the trend to continue with improvements on milk volume and profitability into 2010.
This article is tagged with the following keywords. Find out more about MyNBR Tags